Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study

Table 3 Underlying disease: Comparison between the rebamipide and conventional therapy groups n (%)

	Conventional group (n = 9)	Rebamipide group (n = 6)	Statistical significance
Hypertension	6 (66.7)	2 (33.3)	NS
Hyperlipidemia	0	3 (50.0)	NS
Diabetes mellitus	1 (11.1)	1 (16.7)	NS
Atrial fibrillation	1 (11.1)	0	NS
Cerebral infarction	1 (11.1)	0	NS
Chronic constipation	5 (55.6)	1 (16.7)	NS
Medications
Antihypertensive agents	5 (55.6)	1 (16.7)	NS
Others	1 (11.1)	1 (16.7)	NS
History of abdominal surgery	4 (44.4)	3 (50.0)	NS

Values are expressed in percentages. Percentages were evaluated by the Fisher’s exact test.